Karolinska University Hospital / Karolinska Universitetssjukhuset

Hospital


Location: Solna / Huddinge, Sweden (SE) SE

ISNI: 0000000092415705

ROR: https://ror.org/00m8d6786

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation Study (2022) Lang-Schwarz C, Rubio CA, Vieth M Journal article HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders (2021) Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KO, Hou L, Clark SR, et al. Journal article Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (2021) Schubert KO, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, et al. Journal article Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study (2021) Coombes BJ, Millischer V, Batzler A, Larrabee B, Hou L, Papiol S, Heilbronner U, et al. Journal article Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions (2021) Dias DO, Kalkitsas J, Kelahmetoglu Y, Estrada CP, Tatarishvili J, Holl D, Jansson L, et al. Journal article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes (2021) Tsekrekos A, Vieth M, Ndegwa N, Bateman A, Flejou JF, Grabsch H, Mastracci L, et al. Journal article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality (2021) Bergquist AM, Weismueller T, Levy C, Rupp C, Joshi D, Nayagam J, Montano-Loza AJ, et al. Conference contribution CG-SENSE revisited: Results from the first ISMRM reproducibility challenge (2021) Maier O, Baete SH, Fyrdahl A, Hammernik K, Harrevelt S, Kasper L, Karakuzu A, et al. Journal article, Review article